Email This Article

Headlines & Perspectives
Xoma's Potential Heartbreak of a Psoriasis Drug Delay
By Adam Feuerstein
06/06/01 - 05:31 PM EDT
The Street has an ambitious timeline for Xanelim approval that might not pan out.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,394.11 1,104.56 2,189.05 34.44
Oil *
76.37
UP
5.21
DOWN
1.42
DOWN
5.30
DOWN
0.39
10 Yr
3.44%
SPDR Gold
113.60
+0.05%
-0.13%
-0.24%
-1.12%
Data delayed 20 minutes

Brokerage Partners